BioCompute Conference and Workshop: Difference between revisions

From BCOeditor Wiki
Jump to navigation Jump to search
Line 150: Line 150:
|-
|-
|1:30pm - 1:45pm
|1:30pm - 1:45pm
|'''Elaine Thompson'''
|'''Jonas Almeida'''
<small>Vice President Bioinformatics, Embleema</small>
<small>Vice President Bioinformatics, Senior Investigator; Director, Data Science, NIH/NCI/DCEG</small>
|BCO-CDISC: An emerging role for BioCompute: CDISC Standards for Cell and Gene Therapy Product (CGTP) Monitoring.
|BCO-CDISC: An emerging role for BioCompute: CDISC Standards for Cell and Gene Therapy Product (CGTP) Monitoring.
|-
|-

Revision as of 20:34, 10 April 2024

2024 BioCompute Conference and Workshop

This workshop provides an opportunity to learn about interoperability between platforms that host BioCompute Objects (BCOs), the FDA’s "Portal" for reading, writing and sharing BCOs, real world applications including intended use in regulatory submissions, and potential implementations, including the use of AI/ML. This conference will have perspectives from both FDA and industry around the use of BioCompute in regulatory submissions, challenges for implementation, and tools designed to work with the standard. Join us for an in-depth discussion of BCO standards and an opportunity to view other projects during our poster session.

Event Registration: Eventbrite

Date & Time: May 10th, 2024, 9 AM - 5 PM

Location: Great Room, White Oak Campus, FDA center

Getting there

By Car

Enter "FDA Building 1" in Google Maps, then follow NW Loop Rd to the closest visitor parking, once reach the T-section turn right onto Michelson Rd to vehicle security screening before parking on the White Oak campus. FDA circulator shuttles are available between visitor parking and Building 1. Refer to the FDA website for the campus map.

By metro Public buses:

  • Ride On Bus Route 22 - stops at the Silver Spring (Red line) Metro station
  • BRT Flash Orange Route - stops at the Silver Spring (Red line) Metro station
  • Metro Bus C8 - stops at the White Flint (Red line), Glenmont (Red Line), and College Park (Green line) Metro stations
  • Metro Bus K6 - stops at the Fort Totten (Red, Green, and Yellow lines) Metro station
  • Metro Bus K9 - stops at the Fort Totten (Red, Green, and Yellow lines) Metro station

FDA shuttle to metro:

Please go to the FDA site for more transportation options.

Abstract

Documenting computational workflows has historically been a challenge for researchers and reviewers. Often, there are no clear guidelines for describing these workflows, leading to ad hoc definitions and descriptions that are insufficient for comprehension and reproducibility. BioCompute, an abbreviation for the IEEE standard 2791-2020, offers a structured framework for precisely yet adaptable describing workflows. A BioCompute Object (BCO) represents a workflow that adheres to this standard. This standard breaks down a workflow into its core components, aligning them with established data standards and ontologies. BioCompute significantly aids in streamlining workflow data, managing complexity across multiple versions, and enhancing reproducibility.

As the field evolves, addressing regulatory concerns becomes paramount, necessitating a common language for all stakeholders. The BioCompute community, comprised of over 400 individuals, has crafted a framework that offers guidance without imposing undue burdens on sponsors or reviewers. To date, BCO has been embraced by three FDA centers, effectively reducing delays in regulatory submissions. An ongoing pilot project involving the BioCompute team, FDA, and industry sponsors aims to improve communication efficiency and fluidity during submission and review processes.

The BioCompute Portal, the central platform for creating and submitting BCOs, has seen significant improvements in the past year, including Google and ORCID integration and an enhanced user interface. Furthermore, a new Portal instance at the FDA, along with four tools for authoring BCOs directly from various platforms (BCOnexus, Seven Bridges APP, the HIVE, and Galaxy platforms), and expanded documentation, make it easier to create, share, edit, and publish BCOs online. In addition, the FDA can retrieve BCOs from the public BCODB upon request, and with APIs and authentication tokens, users can directly submit to FDA portal API endpoints and interact with BCOs and their implementations seamlessly. All of the most up-to-date information about BioCompute will be introduced at the workshop and followed by a roundtable discussion to further improve the applicability of BioCompute from the FDA point of view and industry-wise.

Organization Committee

Jonathon Kenney (GWU/Chair); Raja Mazumder (GWU); Mark Walderhaug (FDA); Luis Santana-Quintero(FDA); Charles Hadley King (GWU); Omar Serang (DNAnexus); Sam Westreich (DNAnexus) Dennis A. Dean, II (Velsera); Phil Webster (Velsera); Kostis Karagiannis (Moderna)

Workshop Topics

  • Updates and future for BioCompute
  • Need for BCO at FDA
  • Considerations for Adoption in Industry
  • Progress Towards Usability
  • BCODB and Portal's use at the FDA
  • BCO platform interoperability
  • Exemplar workflows and real-world applications
  • BCO-Nextflow
  • Potential AI/ML-related implementations
  • FAQ session & Roundtable discussion

Poster Session

Participants are encouraged to submit a poster abstract by April 15th, 11:59 PM (EDT). Posters should describe a computational pipeline or topic related to BioCompute. Up to 5 posters will have their workflows converted into a BCO by the BCO team and published in the BCO Portal, and will be offered a 5-minute lightning talk at the end of the conference. All posters must be printed before the workshop and set up at the start of the event.

Abstract: Any computational workflow of interest, or topic related to BCOs

Poster Content: Posters should highlight or describe a workflow (either in progress or one already in use) and the way it is used.

Size: poster sizes can be up to 4' tall x 6' wide.

Submission Portal: click here.

Schedule

Time Speaker Content
9:00am - 10:00am Introduction and Future for BioCompute
9:00am - 9:10am Jonathon Keeney

Research Assistant Professor, George Washington University

Introduction
9:10am - 9:25am Raja Mazumder

Professor, George Washington University

Vision and Future of BioCompute
9:25am - 9:40am Vahan Simonyan

CSO, Embleema

BioCompute vision from an FDA-Industry perspective
9:25am - 10:00am Peter Marks

Director, CBER, FDA

Vision
10:00am - 11:00am Need for BCO at FDA
10:00am - 10:20am Mark Walderhaug

Associate Director for Risk Assessment, CBER, FDA

BioCompute Objects and standards
10:20am - 10:35am Luis Santana-Quintero

HIVE lead, CBER, FDA

Computational Reviews at CBER
10:35am - 10:50am Eric Donaldson

Clinical Virology Reviewer

Perspectives from a Reviewer: High Throughput Sequencing Data Challenges in FDA Regulatory Review
10:50am - 11:00am Discussion
11:00am - 11:20am Break and poster review
11:20am - 12:15am Considerations for Adoption in Industry
11:20am - 11:35am UNCONFIRMED TBD
11:35am - 11:50am Jun Luo

Data Scientist, Novo Nordisk

A computational framework for end-to-end clinical omics analysis: Single cell mechanism of action study in chronic diseases
11:50am - 12:05pm Jack Baker

Scientist, Merck

Considerations for adoption from industry
12:05pm - 12:15pm Discussion
12:15pm - 1:15pm Lunch & Poster Session
1:15pm - 4:10pm Progress Towards Usability
1:15pm - 1:30pm Susan Gregurick

Director of Data Science, NIH

AI for Health and Research: Exploring NIH’s Strategies, Challenges, and Vision for the Future
1:30pm - 1:45pm Jonas Almeida

Vice President Bioinformatics, Senior Investigator; Director, Data Science, NIH/NCI/DCEG

BCO-CDISC: An emerging role for BioCompute: CDISC Standards for Cell and Gene Therapy Product (CGTP) Monitoring.
1:45pm - 2:00pm Guangzhi Sun

Associate Researcher, CNIS

Extending BCO specification into a generic metamodel for computable data
2:00pm - 2:15pm Break and Poster review
2:15pm - 2:30pm Regualtory Advisory Board representative Forthcoming Guidance for BCO Submission
2:30pm - 2:50pm Dennis Dean

Director of Translational Sciences, Velsera

Facilitating BCO Use from Standard to Best Practices: The Neoantigen Workflow Use Case
2:50pm - 3:05pm Sam Westreich

Sr. Scientific Program Manager, DNAnexus

DNAnexus: Democratizing access to BCOs with the BCOnexus Platform-Free Editor
3:05pm - 3:20pm Break and Poster review
3:20pm - 3:35pm Stian Soiland-Reyes and Meznah Aloqalaa

Senior Lecturer, University of Manchester/Ph.D. Student

BCO, provenance models (PRIMAD, RO-Crate) and FAIR Computational Workflows
3:35pm - 3:50pm Ben Sherman

Developer, Seqera Labs

Generating BioCompute objects for Nextflow pipelines
3:50pm - 4:05pm Konstantinos Krampis

Associate Professor of Biology and Computer Science, CUNY

BCO in AI: Leveraging Large Language Models (aka ChatGPT) for Biocompute Object Generation in Bioinformatics
4:05pm - 4:20pm Sean Kim

Bioinformatics Specialist, George Washington University

Enhanced BioCompute Object Creation through Retrieval-Augmented Generation from Scientific Papers
4:20pm - 4:30pm Break and Poster review
4:30pm - 5:00pm Lightning talk and closing
4:30pm - 4:45pm Chosen speakers Poster lightning talks
4:45pm - 5:00pm Closing

Confirmed Presenters

Peter Marks.png
Peter Marks
Susan K. Gregurick.jpg
Susan K. Gregurick
Mazumder, Raja.jpeg.jpg
Raja Mazumder
Vahan Simonyan.png
Vahan Simonyan
Jun Luo.png
Jun Luo
Sam Westreich.jpg
Konstantinos Krampis.jpg
Konstantinos Krampis
Ben Sherman.png
Ben Sherman
Image001.png
Eric Donaldson
Dennis Dean.png
Dennis A. Dean, II
Jonathon Keeney.png
Luis.jpg
Luis Santana-Quintero
Jack Baker.png
Jack Baker
Sean Kim.png
Sean Kim

Contact Us

For questions about registration or general inquiries about BioCompute, please go to Contact Us or refer to our FAQs